Please login to the form below

Not currently logged in
Email:
Password:

RECOVERY trial

This page shows the latest RECOVERY trial news and features for those working in and with pharma, biotech and healthcare.

Regeneron’s COVID-19 drug boosts survival in hospitalised patients lacking antibodies

Regeneron’s COVID-19 drug boosts survival in hospitalised patients lacking antibodies

data. In the UK-based RECOVERY trial, 9, 785 hospitalised COVID-19 patients were randomly allocated to receive usual care plus REGEN-COV (casirivimab and imdevimab) or usual care alone. ... We are incredibly grateful to the RECOVERY team, participating

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...